Luther King Capital Management (LKCM)’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
WP
Luther King Capital Management (LKCM)'s CLB Position: Q2 2017 in Review
Luther King Capital Management (LKCM) sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 2,867 shares — an estimated $331K sold.
Luther King Capital Management (LKCM) first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $4.85M in Q4 2015. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.
- Luther King Capital Management (LKCM) reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
- Luther King Capital Management (LKCM) sold 2,867 Core Laboratories shares in Q2 2017, an estimated $331K.
- Luther King Capital Management (LKCM) first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
- Luther King Capital Management (LKCM)'s Core Laboratories position peaked at $4.85M in Q4 2015.
- 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2017, filed 10 Aug 2017.